The role of inflammation in adjuvant chemotherapy-induced sarcopenia (Izmir Oncology Group (IZOG) study).

Utku OflazogluAhmet AlacaciogluUmut VarolYuksel KucukzeybekTarik SalmanHulya Tas OnalHuriye Erbak YilmazYasar YildizHalil TaskaynatanSeray SarayOsman ButunM Oktay Tarhan

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2020)

The present prospective observational study suggested an association of chemotherapy-induced sarcopenia with inflammatory markers Hs-CRP, IL8, and TNF-α. Inflammation may play a role in chemotherapy-induced sarcopenia in newly diagnosed non-metastatic patients.

Keyphrases

chemotherapy induced
newly diagnosed
skeletal muscle
oxidative stress
end stage renal disease
small cell lung cancer
ejection fraction
chronic kidney disease
squamous cell carcinoma
palliative care
rheumatoid arthritis
diabetic rats
high glucose
peritoneal dialysis
patient reported outcomes